The Review Course on Friday, November 11, at ACR Convergence serves as a refresher on proven strategies and an introduction to the latest developments and current guidelines in rheumatology. The full-day, advance programming session features eight presentations by experts in the highlighted specialties.
“It’s relevant to anyone who’s in clinical practice,” said co-moderator Julie Schwartzman-Morris, MD, MS. “The idea behind the Review Course is to present concise, targeted information on important and relevant topics every year to give the learners a way of keeping current on the most common diagnoses that we see.”
A diverse panel of national and international speakers will discuss Sjögren’s syndrome, spondyloarthritis, metabolic bone disease, osteoarthritis, statin myopathy, paraneoplastic syndromes, and autoinflammatory syndromes.
“For providers who are working out in the community, they may recall a disease from their fellowship training, but they see a case once every few years. Because of that rarity, they may have an understanding of the disease and how to treat it, but they don’t know the new updates in that disease,” said co-moderator Noelle A. Rolle, MBBS, FACR. “This is an opportunity to hear the most up-to-date new information on how to diagnose and manage those cases.”
The topics change each year and cover a range of conditions, making it an important extension of learning beyond research publications and reference readings for new and returning participants.
“You are able to access experts in the field and ask applicable questions that you haven’t found in the literature,” Dr. Rolle said. “As a fellow, I always looked forward to the Review Course for updates and emphasis on areas that I needed to learn. There is great benefit for trainees here as well. This Review Course is a way in which you can get updated on the new techniques and the new ways of managing cases or investigating them.”
Staying up to date on evolving guidelines is crucial to patient care.
“In rheumatology, if there was a guideline or a form of management five years ago, it’s likely changed, because it’s such a fast-growing specialty. This makes sessions like the Review Course even that much more important for rheumatology,” Dr. Rolle said.
The Review Course will take place 9 a.m.–3 p.m. ET in Exhibit Hall A of the Philadelphia Convention Center. It will be livestreamed and available on demand for all registered ACR Convergence attendees following the meeting.
The day’s program is as follows.
- Sjögren’s and Sjögren’s Mimics: 9:05–9:45 a.m. ET, Sara McCoy, MD, PhD, RhMSUS, University of Wisconsin
- Spondyloarthritis: 9:45–10:25 a.m. ET, Jose U. Scher, MD, New York University School of Medicine
- Metabolic Bone Disease: 10:25–11:05 a.m. ET, S. Bobo Tanner, CCD, MD, Vanderbilt University Medical Center
- Break: 11:05–11:20 a.m. ET
- Osteoarthritis in 2022: 11:20 a.m.–12 p.m. ET, Carla Scanzello, MD, PhD, University of Pennsylvania
- Statin Myopathy: 12–12:40 p.m. ET, Lisa Christopher-Stine, MD, MPH, Johns Hopkins University
- Break: 12:40–12:55 p.m. ET
- Paraneoplastic Syndromes: 12:55–1:35 p.m. ET, Laura Cappelli, MD, Johns Hopkins School of Medicine
- Management of Raynaud’s Disease: 1:35–2:15 p.m. ET, John Pauling, PhD, BSc, FRCP, MBBCH, North Bristol NHS Trust
- Diagnosis and Management of Autoinflammatory Syndromes: 2:15–2:55 p.m. ET, Daniel Kastner, MD, PhD, National Human Genome Research Institute